PLGA Nanoparticles for Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: A Novel Approach towards Reduction of Renal Radiation Dose

Preparation of Patient Doses of 177Lu-DOTA-TATE Using Indigenously Produced 177Lu: The Indian Experience

(2011) Tapas Das et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Nanotargeted Radionuclides for Cancer Nuclear Imaging and Internal Radiotherapy

(2010) Gann Ting et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention

(2010) E. Vegt et al.   JOURNAL OF NUCLEAR MEDICINE

PEGylated PLGA nanoparticles for the improved delivery of doxorubicin

(2009) Jason Park et al.   Nanomedicine-Nanotechnology Biology and Medicine

Intraoperative 186Re-Liposome Radionuclide Therapy in a Head and Neck Squamous Cell Carcinoma Xenograft Positive Surgical Margin Model

(2008) S. X. Wang et al.   CLINICAL CANCER RESEARCH

Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats

(2008) D. R. Kalaria et al.   PHARMACEUTICAL RESEARCH

The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats

(2007) S DADASHZADEH et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS